Top Markets
Coin of the day
Actuate Therapeutics Inc Actuate Therapeutics Inc

Actuate Therapeutics Inc

ACTU
株式のランク #28698
Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the... Actuate Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating treatments for various cancers. Its primary drug candidate is Elraglusib Injection, an innovative glycogen synthase kinase-3 (GSK-3) inhibitor designed to combat metastatic pancreatic ductal adenocarcinoma. Furthermore, Elraglusib is being developed to address other malignancies, including Ewing sarcoma, metastatic melanoma, and colorectal cancer. Originally named Apotheca Therapeutics, Inc., the organization rebranded as Actuate Therapeutics, Inc. in October 2015. Established in 2015, the company maintains its headquarters in Fort Worth, Texas.
株価
$1.05
時価総額
$25.12M
変化(1日)
0.00%
変化(1年)
-86.83%
US
取引 Actuate Therapeutics Inc (ACTU)

カテゴリー

Actuate Therapeutics Inc(ACTU)の株価履歴
終値の最高値: $1.04 (2026-08-01)

終値の最安値: $8.39 (2024-08-01)
Actuate Therapeutics Inc の株価履歴(2024 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) -36.39%
2025 -14.02%
2024 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$552.07 41.28%
US
$168.77 504.69%
US
$1.03K 57.19%
NL
$117.42 -19.34%
AU
$753.28 8.59%
CH